Genotype and Phenotype Analysis in Pediatric Patients with Cystinuria

Ji Hyun Kim1, Eujin Park1, Hye Sun Hyun1

  • 1Department of Pediatrics, Seoul National University Children's Hospital, Seoul, Korea.

Insights

Cystinuria, a kidney disorder, shows varied genetic causes in Korean children. Early onset was linked to non-SLC3A1 mutations, with all patients experiencing kidney stones.

Area of Science:

  • Nephrology
  • Genetics
  • Pediatric Medicine

Background:

  • Cystinuria is an inherited renal disorder causing cystine and dibasic amino acid malabsorption.
  • This defect leads to nephrolithiasis (kidney stone formation).
  • Understanding genetic and clinical features is crucial for managing pediatric cases.

Purpose of the Study:

  • To investigate the genotypes and phenotypes of pediatric cystinuria patients in Korea.
  • To identify specific mutations in genes SLC3A1 and SLC7A9.
  • To explore potential genotype-phenotype correlations.

Main Methods:

  • Retrospective analysis of eight pediatric cystinuria patients.
  • Mutational studies using direct sequencing.
  • Clinical data collection including age at onset, diagnosis, follow-up, and complications.

Main Results:

  • Seven patients underwent mutational analysis, revealing biallelic SLC3A1 (AA) in 4, heterozygous SLC3A1 (A-) in 1, biallelic SLC7A9 (BB) in 1, and heterozygous SLC7A9 (B-) in 1.
  • Two novel mutations were identified.
  • No significant genotype-phenotype correlation was observed, except for earlier onset in non-AA genotypes.
  • All patients had recurrent symptomatic nephrolithiasis requiring interventions.
  • Three patients developed mild-to-moderate renal dysfunction.

Conclusions:

  • This study presents the first genotypic and phenotypic analysis of cystinuria in Korean pediatric patients.
  • Genetic variations in SLC3A1 and SLC7A9 are implicated in pediatric cystinuria.
  • Recurrent nephrolithiasis and potential renal dysfunction are significant complications.
  • Further research may clarify genotype-phenotype relationships and inform treatment strategies.

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
977
Pedigree Analysis01:35

Pedigree Analysis

Overview
90.3K
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes01:28

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes

Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450...
81
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
306
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
967
Karyotyping01:17

Karyotyping

Overview
69.5K